BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3906673)

  • 21. Alprazolam and diazepam in the treatment of generalized anxiety.
    Elie R; Lamontagne Y
    J Clin Psychopharmacol; 1984 Jun; 4(3):125-9. PubMed ID: 6145726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the effect of diazepam on spasticity.
    Cocchiarella A; Downey JA; Darling RC
    Arch Phys Med Rehabil; 1967 Aug; 48(8):393-6. PubMed ID: 4952530
    [No Abstract]   [Full Text] [Related]  

  • 23. Electrophysiological analysis of the mode of action of muscle relaxants in spasticity.
    Delwaide PJ
    Ann Neurol; 1985 Jan; 17(1):90-5. PubMed ID: 3985591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous diazepam infusion in the management of planned intrathecal baclofen withdrawal.
    Cruikshank M; Eunson P
    Dev Med Child Neurol; 2007 Aug; 49(8):626-8. PubMed ID: 17635210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multi-centre comparison of prazepam and diazepam in the treatment of anxiety.
    Dorman T
    Pharmatherapeutica; 1983; 3(6):433-40. PubMed ID: 6353434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reflex cervical muscle spasm: treatment by diazepam, phenobarbital or placebo.
    Basmajian JV
    Arch Phys Med Rehabil; 1983 Mar; 64(3):121-4. PubMed ID: 6338860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion.
    Dario A; Scamoni C; Bono G; Ghezzi A; Zaffaroni M
    Funct Neurol; 2001; 16(4):311-5. PubMed ID: 11853321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spasticity and its treatment].
    Larsen TA; Teräväinen H
    Duodecim; 1985; 101(12):1216-9. PubMed ID: 4017913
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacological rebound: a tool in the evaluation of antispasticity drugs.
    Roussan MS; Abramson AS; Levine SA; Feibel A
    Arch Phys Med Rehabil; 1976 Nov; 57(11):504-7. PubMed ID: 791192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis.
    Brar SP; Smith MB; Nelson LM; Franklin GM; Cobble ND
    Arch Phys Med Rehabil; 1991 Mar; 72(3):186-9. PubMed ID: 1998451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of intravenous ethanol versus diazepam for alcohol withdrawal prophylaxis in the trauma ICU: results of a randomized trial.
    Weinberg JA; Magnotti LJ; Fischer PE; Edwards NM; Schroeppel T; Fabian TC; Croce MA
    J Trauma; 2008 Jan; 64(1):99-104. PubMed ID: 18188105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic and surgical therapy for spasticity.
    Tibbs PA; Young AB; Walsh JW; Bean JR
    J Ky Med Assoc; 1981 Jun; 79(6):359-62. PubMed ID: 7264443
    [No Abstract]   [Full Text] [Related]  

  • 33. Ketazolam once daily for spasticity: double-blind cross-over study.
    Basmajian JV; Shankardass K; Russell D
    Arch Phys Med Rehabil; 1986 Aug; 67(8):556-7. PubMed ID: 2874780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intrathecal baclofen in the treatment of severe spastic tetraplegia and dystonia in children and adolescents].
    Illum NO; Hansen FJ; Fischer C; Uldall PV; Nielsen OA
    Ugeskr Laeger; 2003 Apr; 165(17):1755-9. PubMed ID: 12768902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind crossover study of diazepam rectal suppositories, 5 mg and 10 mg, for sedation in patients with advanced malignant disease.
    Ehsanullah RS; Galloway DB; Gusterson FR; Kingsbury AW
    Pharmatherapeutica; 1982; 3(3):215-20. PubMed ID: 6752963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychosomatic disorders in general practice: comparisons of treatment with flupenthixol, diazepam and sulpiride.
    Meyers C; Vranckx C; Elgen K
    Pharmatherapeutica; 1985; 4(4):244-50. PubMed ID: 3903789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen.
    Stien R; Nordal HJ; Oftedal SI; Slettebø M
    Acta Neurol Scand; 1987 Mar; 75(3):190-4. PubMed ID: 3554879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The parents expectations after baclofen pump implantation in child with severe spasticity in physical rehabilitation and psychological aspects].
    Fafara A; Kwiatkowski S; Kawecka J; Grzegorzewski P; Kawecki Z
    Przegl Lek; 2007; 64 Suppl 2():18-21. PubMed ID: 17953274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of hydrotherapy for the management of spasticity.
    Kesiktas N; Paker N; Erdogan N; Gülsen G; Biçki D; Yilmaz H
    Neurorehabil Neural Repair; 2004 Dec; 18(4):268-73. PubMed ID: 15537997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of baclofen in treatment of spasticity in multiple sclerosis.
    Sawa GM; Paty DW
    Can J Neurol Sci; 1979 Aug; 6(3):351-4. PubMed ID: 385132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.